CClinicalTrials.gg
CompletedNCT04689568Updated Mar 23, 2023

Improving Depression Via E-Health Access (IDEA) Study

An interventional study of Moodkit and Moodgym in Depression, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-23.

Sponsored by University of Michigan · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The researchers are doing this study to learn more about which online self-help resources, including a smartphone app, an online program, or an informational website, primary care patients with depression are likely to choose and whether the chosen tool will improve their depressive symptoms and wellbeing. The researchers would also like to know how likely someone is to use the resources and their satisfaction with the resources.

Read the detailed description

Participants will be using a self-help resource for the 6-week study period. A Care Manager will contact participants by phone, once a week, for about 5-10 minutes at a pre-arranged time. Participation will be needed for 10 weeks in total (6 weeks of active participation and a survey 1-month after the study intervention ends).

Subscription-based self-help resources being tested during the study will not be freely available after the study period. However, the researchers will share information on how to access these resources for a fee after the study period to all participants.

In addition to the time above, the researchers will collect information from participant's medical records for another 10 months after participation. The entire study is expected to last about 2 years.

02

Conditions studied

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 32 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals who are English-speaking
  • Individuals with a Patient Health Questionnaire 9 (PHQ9) score greater than or equal to 11 or diagnosis of moderate to severe depression determined by the Care Manager during her initial psychiatric evaluation and by the study PI during panel review will supersede a low PHQ9 score.
  • Individuals with have daily internet access and a smartphone;
  • Individuals who agree to periodic contact with the care manager and study team.

Exclusion criteria

Exclusion Criteria:

  • Individuals who have cognitive impairment that would preclude use of self-help resources
  • Individuals with already using an electronic mental health resource;
  • Individuals with unstable medical illness, e.g. active cancer;
  • Individuals with severe psychiatric symptoms (marked suicidality, psychotic symptoms, severe substance abuse)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Moodkit

    MoodKit is a cognitive behavioral therapy (CBT)-based app designed to provide tools for managing depressed mood, anxiety and stress.

    Behavioral: Moodkit

  • Active comparator
    Moodgym

    Moodgym is an online cognitive behavioral therapy (CBT)-based program designed to prevent or reduce symptoms of depression and anxiety by helping users identify and overcome problem emotions and to develop good coping skills.

    Behavioral: Moodgym

  • Active comparator
    University of Michigan Depression Center Toolkit

    The Toolkit provides information, tools, support, and resources to guide individuals through their mental health journey. The Toolkit offers help to people who are experiencing problems with a mood disorder as well as with stress and anxiety.

    Behavioral: University of Michigan Depression Center Toolkit

Interventions

  • BehavioralMoodkit

    MoodKit is divided into four main sections: Activities, Thoughts, Mood and Journal. In the Thoughts section, the user is asked to briefly describe stressful situations and their reactions to the event and is later educated on a number of "thought distortions". In the Mood section, the user is asked to give an overall rating of mood, which can be done several times per day. In the Journal section, the user can write freestanding journal entries. Additional areas of advice and goal setting are contained in a section called Thrive Tips.

  • BehavioralMoodgym

    The program consists of five modules each taking 20- to 40-minutes to complete, which are completed in a prescribed order.

  • BehavioralUniversity of Michigan Depression Center Toolkit

    The Toolkit provides information, tools, support, and resources to guide individuals through their mental health journey.

06

What researchers measure

Primary outcomes

  1. Patient preference, use and satisfaction of the intervention as assessed by timed structured survey

    Time frame: Up to 14 months

  2. Patient frequency and duration of intervention use and satisfaction as assessed by weekly structured survey

    Structured survey conducted weekly.

    Time frame: Up to 14 months

  3. Patient preference and satisfaction with the intervention as assessed by qualitative interviews

    Interviews are semi-structured and audio recorded

    Time frame: Up to approximately 14 months

  4. Care manager experiences of the intervention as assessed by qualitative interviews

    Interviews are semi-structured and audio recorded

    Time frame: Up to approximately 18 months

  5. Clinician/Administrator views related to interventions as assessed by qualitative interviews

    Interviews are semi-structured and audio recorded

    Time frame: Up to approximately 18 months

  6. Patient frequency of intervention use as assessed by self-report use of tools

    As recorded in participants' printed copy of their mood-logs from the app or program.

    Time frame: Up to 14 months

  7. Change in severity of symptoms of depression as assessed with the Patient Health Questionnaire 9 (PHQ-9) score

    The PHQ-9 is an instrument for screening, diagnosing, monitoring and measuring the severity of depression: The PHQ-9 has a range of scores from 0-27. Depression Severity: 0- none, 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.

    Time frame: At baseline (before choosing an intervention) and at week 6 (when they complete the intervention)

  8. Change in level of functioning as assessed with the Sheehan Disability Scale (SDS)

    The Sheehan Disability Scale (SDS) is a 5-item clinician-rated questionnaire used to evaluate impairments in the domains of work, social life/leisure, and family life/home responsibility. All items are rated on a continuum (0 = no impairment to 10 = most severe) with the total SDS score ranging from 0 (no impairment) to 30 (most severe)

    Time frame: At baseline (before choosing an intervention) and at week 6 (when they complete the intervention)

07

Study locations

1 site
  • The University of Michigan
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04689568
Lead sponsor
University of Michigan
Responsible party
Jennifer Severe (Assistant Professor of Psychiatry, University of Michigan) — Principal investigator
First posted
Dec 30, 2020
Start date
Jan 27, 2021
Primary completion
Jul 1, 2022
Completion
Jul 1, 2022
Last update
Mar 23, 2023

Study contacts

Jennifer Severe, MD
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion